These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1370766)

  • 21. [Characteristic and effective usage of adriamycin].
    Horiuchi K; Akimoto M
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines].
    Ota K; Goto T; Fukushima M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1352-61. PubMed ID: 6191712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.
    Topuz E; Salihoglu Y; Aydiner A; Saip P; Tas F; Sozen T; Berkman S; Bengisu E
    J Surg Oncol; 2000 Jul; 74(3):223-6. PubMed ID: 10951423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Continuous venous infusion in cancer chemotherapy].
    Ota K
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):798-805. PubMed ID: 2580486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery.
    Zou Y; Yamagishi M; Horikoshi I; Ueno M; Gu X; Perez-Soler R
    Cancer Res; 1993 Jul; 53(13):3046-51. PubMed ID: 8319211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical setting and pharmacology of intraperitoneal chemotherapy: an overview.
    Myers CE
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):12-6. PubMed ID: 4048971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience).
    Markman M; Reichman B; Hakes T; Hoskins W; Rubin S; Jones W; Lewis JL
    Acta Med Austriaca; 1989; 16(3-4):65-7. PubMed ID: 2609915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flexible versus rigid catheters for chronic administration of exogenous agents into central nervous system tissues.
    Guarnieri M; Carson BS; Khan A; Penno M; Jallo GI
    J Neurosci Methods; 2005 Jun; 144(2):147-52. PubMed ID: 15910972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies.
    Vexler AM; Mou X; Gabizon AA; Gorodetsky R
    Int J Cancer; 1995 Mar; 60(5):611-5. PubMed ID: 7532157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketorolac tromethamine, a nonsteroidal anti-inflammatory drug: ability to inhibit post-radical pelvic surgery adhesions in a porcine model.
    Montz FJ; Monk BJ; Lacy SM; Fowler JM
    Gynecol Oncol; 1993 Jan; 48(1):76-9. PubMed ID: 8423025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of postsurgical cell infiltration and fibrinolytic activity by tolmetin in two species.
    Rodgers KE; Ellefson DD; Girgis W; diZerega GS
    J Surg Res; 1994 Apr; 56(4):314-25. PubMed ID: 8152224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II to IV non-Hodgkin's lymphomas with intermediate- or high-grade histology.
    Gherlinzoni F; Guglielmi C; Mazza P; Amadori S; Mandelli F; Tura S
    Semin Oncol; 1990 Dec; 17(6 Suppl 10):3-8; discussion 8-9. PubMed ID: 1701924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycin.
    Sadzuka Y; Nakai S; Miyagishima A; Nozawa Y; Hirota S
    Cancer Lett; 1997 Jan; 111(1-2):77-86. PubMed ID: 9022131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catheter complications associated with intraperitoneal chemotherapy.
    Topuz E; Saip P; Aydiner A; Salihoglu Y; Aydin Y; Topuzlu C
    Eur J Gynaecol Oncol; 1998; 19(3):275-9. PubMed ID: 9641230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole.
    Goel R; Cleary SM; Horton C; Balis FM; Zimm S; Kirmani S; Howell SB
    J Clin Oncol; 1989 Feb; 7(2):262-9. PubMed ID: 2915241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of recurrent and metastatic cervical carcinoma. Evaluation of an antiblastic combination of methotrexate-adriamycin-bleomycin (MAB).
    Adamo V; Altavilla G; Buemi B; Caristi N; Scalisi R; Tropea F
    Chemioterapia; 1985 Apr; 4(2):143-6. PubMed ID: 2408771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration.
    Alberts DS; Young L; Mason N; Salmon SE
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):38-42. PubMed ID: 3931226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of intraperitoneal chemotherapy in the treatment of ovarian cancer.
    Myers C
    Semin Oncol; 1984 Sep; 11(3):275-84. PubMed ID: 6385257
    [No Abstract]   [Full Text] [Related]  

  • 39. Adhesion prevention with ancrod released via a tissue-adherent hydrogel.
    Chowdhury SM; Hubbell JA
    J Surg Res; 1996 Feb; 61(1):58-64. PubMed ID: 8769943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A study of the use of methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, bleomycin (MVP-CAB) in metastatic transitional cell carcinoma].
    Fujii A; Den S; Nakamura I; Ohshima H; Nagata H; Izumi T; Takechi Y; Kawaida T; Kamidono S; Yasuno H
    Hinyokika Kiyo; 1987 May; 33(5):697-703. PubMed ID: 2444083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.